THTianren Hu

Tianren Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tianren Hu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Guanghua Huang

    Fudan University

    4 shared publications
  • Clarissa J. Nobile

    Department of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, USA

    2 shared publications
  • Haiqing Chu

    Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China; Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China

    2 shared publications
  • Jian Bing

    State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Shanghai Institute of Infectious Disease and Biosecurity, and Department of infectious diseases, Huashan Hospital, Fudan University, Shanghai 200438, China

    2 shared publications
  • Qiushi Zheng

    College of Pharmaceutical Sciences, Southwest University, Chongqing, China

    2 shared publications
  • Austin M Perry

    Department of Molecular and Cell Biology, University of California, Merced, Merced, California, USA

    1 shared publication

Latest Publications

  • Biological characterization of Candida parapsilosis haploids induced by voriconazole

    by Lingyu Ji, Tianhong Zheng, Tianren Hu, Shuaihu Li, Jian Bing, Qiushi Zheng, Haiqing Chu, Guanghua Huang

  • Genetic and environmental control of parasexual reproduction in the pathogenic Candida species

    by Chengjun Cao, Li Tao, Tianren Hu, Haiqing Chu, Austin M Perry, Clarissa J Nobile, Guanghua Huang

    SUMMARY: Candida species are major yeast pathogens that cause both mucosal candidiasis and life-threatening invasive infections. Most Candida species, including Candida albicans , have long been thought to be “imperfect” due to the lack of a complete sexual reproduction cycle. Since the discovery of the mating type-like locus in C. albicans in 1999, the regulation of (para)sexual reproduction has been intensively investigated in this organism as well as in several phylogenetically closely related species. The (para)sexual cycle is not only critical for the generation of genetic and phenotypic diversity but is also involved in the regulation of other biological processes, such as morphological transitions, biofilm development, and virulence in pathogenic fungi. In this review article, we focus on the unique characteristics and genetic and environmental regulatory mechanisms of parasexual reproduction in the pathogenic Candida species. We discuss the relationship between the white-opaque switching and mating in the Candida species, particularly in C. albicans . We describe recent findings on environmental factors, genetic regulators, and key signaling pathways involved in sexual mating in C. albicans and related species. Finally, we discuss the mating potential and associated regulatory machinery in several Candida species, where parasexual reproduction has not been observed and bring to light some open-ended questions regarding the unique features of parasexual reproduction that should be addressed in future studies in the field.


  • Hotspot mutations and genomic expansion of ERG11 are major mechanisms of azole resistance in environmental and human commensal isolates of Candida tropicalis

    by Tianren Hu, Sijia Wang, Jian Bing, Qiushi Zheng, Han Du, Chao Li, Zhangyue Guan, Feng-Yan Bai, Clarissa J. Nobile, Haiqing Chu, et al.


  • Top Cited Papers
    Open Access

    Candida auris: Epidemiology, biology, antifungal resistance, and virulence

    by Han Du, Jian Bing, Tianren Hu, Craig L. Ennis, Clarissa J. Nobile, Guanghua Huang

    First described in 2009 in Japan, the emerging multidrug-resistant fungal pathogen Candida auris is becoming a worldwide public health threat that has been attracting considerable attention due to its rapid and widespread emergence over the past decade. The reasons behind the recent emergence of this fungus remain a mystery to date. Genetic analyses indicate that this fungal pathogen emerged simultaneously in several different continents, where 5 genetically distinct clades of C. auris were isolated from distinct geographical locations. Although C. auris belongs to the CTG clade (its constituent species translate the CTG codon as serine instead of leucine, as in the standard code), C. auris is a haploid fungal species that is more closely related to the haploid and often multidrug-resistant species Candida haemulonii and Candida lusitaniae and is distantly related to the diploid and clinically common fungal pathogens Candida albicans and Candida tropicalis. Infections and outbreaks caused by C. auris in hospitals settings have been rising over the past several years. Difficulty in its identification, multidrug resistance properties, evolution of virulence factors, associated high mortality rates in patients, and long-term survival on surfaces in the environment make C. auris particularly problematic in clinical settings. Here, we review progress made over the past decade on the biological and clinical aspects of C. auris. Future efforts should be directed toward understanding the mechanistic details of its biology, epidemiology, antifungal resistance, and pathogenesis with a goal of developing novel tools and methods for the prevention, diagnosis, and treatment of C. auris infections.